June 1 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS - HAS BECOME EXCLUSIVE CANADIAN DISTRIBUTOR FOR MYCARE INSITE POINT-OF-CARE DEVICE
* HLS THERAPEUTICS - HAS BECOME EXCLUSIVE CANADIAN DISTRIBUTOR FOR MYCARE RELATED LINE OF DIAGNOSTIC TESTS FROM SALADAX BIOMEDICAL